Deep search
Search
Images
Videos
Maps
News
Shopping
Copilot
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
22m
After Eli Lilly's 7% Slump On Its Guidance Cut, What's Left To Like? A Lot, Says One Analyst.
There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its ...
1h
on MSN
Doctor reveals alarming new symptom he's seeing in Ozempic patients
Dr Daniel Rosen, who is a surgeon and obesity medicine specialist based out of New York, says a 'legitimate number' of his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Israel, Hamas ceasefire deal
Los Angeles wildfire updates
California fires: How to help
Bans use of Red No. 3 dye
‘Cheers’ actor dies at 79
Plans tax hikes on rich
Trans sports bill passed
New definition of obesity
Announces run for governor
Designates 2 monuments
New agency to collect tariffs
FBI erases Chinese malware
Pam Bondi testifies
MS-13 member guilty
Hit with $100M verdict
Inflation ticked up to 2.9%
Federal report on alcohol
SEC sues Elon Musk
Faces $650M+ DOJ lawsuit
CA withdraws EPA requests
Zelenskyy visits Poland
Reviews Texas age law
No federal charges in death
RU missile attack on UKR
2 lunar landers launched
To lay off 5% of staff
Breaks Federer record
1st quarter deficit: $711B
Related topics
Eli Lilly and Company
Zepbound
Ozempic
Weight loss
National Health Service
Feedback